Stryker announces definitive agreement for the sale of its U.S. spinal implants business and plans to sell related international business
28 Janeiro 2025 - 6:05PM
Stryker (NYSE:SYK), a global leader in medical technologies,
announced today a definitive agreement to sell its U.S. spinal
implants business to Viscogliosi Brothers, LLC, a family-owned
investment firm specializing in the neuro-musculoskeletal space, to
create a newly formed company called VB Spine, LLC.
“We believe that the spinal implants business, with its
comprehensive portfolio and strong sales channel, will thrive as an
independent company," said Kevin A. Lobo, Chair and Chief Executive
Officer, Stryker. "With dedicated resources and a focused strategy,
the business will be well positioned to succeed as part of
Viscogliosi Brothers.”
After closing, VB Spine will become a strategic partner to
Stryker with exclusive access to Mako Spine and Copilot for use
with VB Spine’s implants in spine procedures. The transaction will
enhance the focus of both Stryker and VB Spine to meet the needs of
customers and their patients and is expected to achieve faster
growth and deliver greater value for all stakeholders.
“We have long admired Stryker for its comprehensive spine
portfolio, incredible talent, and strong culture,” said Marc, John
and Anthony Viscogliosi, Co-Founders of Viscogliosi Brothers, LLC.
“We see a tremendous opportunity to provide the focus,
surgeon-centric innovation, and commercial execution needed to grow
the business and further impact patient lives and outcomes.”
The definitive agreement also includes a binding offer to
acquire Stryker’s spinal implants business in France, subject to
required consultations with employees and/or employee
representatives. The sale of Stryker’s spinal implants business in
other international markets is anticipated, pending satisfaction of
legal and regulatory requirements, including any required
consultations. The transaction is expected to close in the U.S. in
the first half of 2025, subject to customary closing conditions.
Stryker’s U.S. spinal implants business and VB Spine will
continue to operate as separate entities and proceed with business
as usual until the transaction closes.
In connection with the transaction, Barings, LLC is an investor
and financial partner to Viscogliosi Brothers.
About Stryker
Stryker is a global leader in medical technologies and, together
with our customers, we are driven to make healthcare better. We
offer innovative products and services in MedSurg, Neurotechnology
and Orthopaedics that help improve patient and healthcare outcomes.
Alongside our customers around the world, we impact more than 150
million patients annually. More information is available at
www.stryker.com.
About Viscogliosi Brothers
Viscogliosi Brothers is a family-owned New York City-based
family office dedicated to driving growth and innovation in the
neuro-musculoskeletal industry. Established in 1999, the firm
focuses on identifying and building groundbreaking innovations in
healthcare, aiming to address unmet clinical needs, enhance patient
outcomes, and drive cost efficiency in the healthcare system. Since
its inception 26 years ago, Viscogliosi Brothers has founded,
financed, operated and grown 42 businesses with operations and
distribution across more than 80 countries. These businesses have
positively impacted millions of patients with cutting-edge
innovations in healthcare. The firm has led the transformation of
multiple businesses in the spine industry specifically including:
Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical,
Centinel Spine, Companion Spine, Spine BioPharma and Woven
Orthopedics Technologies, among others. For more information, visit
https://www.vbllc.com/.
About Barings
Barings is a $421+ billion* global asset management firm that
partners with institutional, insurance, and intermediary clients,
and supports leading businesses with flexible financing solutions.
The firm, a subsidiary of MassMutual, seeks to deliver excess
returns by leveraging its global scale and capabilities across
public and private markets in fixed income, real assets and capital
solutions.*Assets under management as of December 31, 2024
Contacts
For investor inquiries please contact:Jason Beach, Vice
President, Finance and Investor Relations at 269-385-2600
orjason.beach@stryker.com
John Nguyen, Senior Director, Investor Relations at 269-385-2600
or john.nguyen1@stryker.com
For media inquiries please contact:Jenny Braga, Director,
Communications and Public Relations at 269-385-2600 or
jenny.braga@stryker.com
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Jan 2025 até Fev 2025
Stryker (NYSE:SYK)
Gráfico Histórico do Ativo
De Fev 2024 até Fev 2025